Kineret — Medical Mutual
Cryopyrin-Associated Periodic Syndromes (CAPS): NOMID, CINCA, FCAS, MWS
Initial criteria
- Kineret is being used for treatment of CAPS (NOMID, CINCA syndrome, FCAS, or MWS)
- Kineret is prescribed by or in consultation with a rheumatologist, geneticist, or a dermatologist
- Site of care medical necessity is met
Reauthorization criteria
- Patient has had a response as determined by the prescriber
- Site of care medical necessity is met
Approval duration
initial 6 months; reauth 1 year